Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.11 Insider Own28.35% Shs Outstand57.91M Perf Week29.04%
Market Cap249.59M Forward P/E- EPS next Y-1.39 Insider Trans-0.21% Shs Float41.49M Perf Month31.00%
Income-48.74M PEG- EPS next Q-0.17 Inst Own57.73% Short Float1.64% Perf Quarter90.71%
Sales0.00M P/S- EPS this Y10.49% Inst Trans4.36% Short Ratio1.53 Perf Half Y-31.04%
Book/sh4.84 P/B0.89 EPS next Y-46.81% ROA-19.91% Short Interest0.68M Perf Year-18.22%
Cash/sh3.72 P/C1.16 EPS next 5Y9.70% ROE-20.44% 52W Range1.81 - 11.31 Perf YTD12.24%
Dividend Est.- P/FCF- EPS past 5Y- ROI-17.39% 52W High-61.89% Beta0.10
Dividend TTM- Quick Ratio35.85 Sales past 5Y-38.46% Gross Margin- 52W Low138.11% ATR (14)0.23
Dividend Ex-Date- Current Ratio35.85 EPS Y/Y TTM-17.48% Oper. Margin0.00% RSI (14)74.52 Volatility7.73% 6.26%
Employees40 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price13.75
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q9.64% Payout- Rel Volume0.00 Prev Close4.31
Sales Surprise- EPS Surprise8.64% Sales Q/Q- EarningsNov 13 BMO Avg Volume443.20K Price4.31
SMA2027.78% SMA5022.19% SMA200-3.79% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Dec-12-23Initiated Deutsche Bank Buy $8
Jul-20-23Resumed BofA Securities Buy $9 → $14
May-18-23Initiated Cantor Fitzgerald Overweight $13
Jul-15-22Initiated BTIG Research Buy $15
Jun-30-22Initiated H.C. Wainwright Buy $15
Jan-21-22Upgrade BofA Securities Neutral → Buy $16 → $14
Jul-26-21Initiated UBS Buy $27
Jul-26-21Initiated Stifel Buy $27
Jul-26-21Initiated Credit Suisse Outperform $26
Jul-26-21Initiated BofA Securities Neutral $20
Feb-29-24 09:40AM
Feb-21-24 08:00AM
Feb-01-24 07:00AM
Jan-30-24 02:14PM
Jan-24-24 01:58PM
04:15PM Loading…
Jan-04-24 04:15PM
Nov-14-23 08:53AM
Nov-13-23 11:08PM
Nov-07-23 04:01PM
Nov-06-23 04:01PM
07:30AM Loading…
Nov-02-23 04:00PM
Oct-27-23 09:25AM
Oct-04-23 08:00AM
Sep-19-23 04:00PM
Sep-06-23 04:00PM
Aug-08-23 10:21PM
Aug-01-23 04:00PM
Jul-25-23 01:47PM
Jul-18-23 10:31PM
Jul-17-23 04:53PM
Jul-16-23 03:00AM
02:00AM Loading…
Jul-03-23 05:13PM
Jun-28-23 06:30AM
Jun-13-23 07:00AM
May-16-23 12:41PM
May-09-23 07:00AM
May-04-23 04:01PM
May-02-23 04:01PM
Apr-09-23 08:57AM
Mar-29-23 07:30AM
Mar-28-23 08:00AM
Mar-27-23 07:00AM
Mar-22-23 04:01PM
Mar-20-23 04:01PM
Mar-08-23 04:01PM
Feb-15-23 12:07PM
Feb-13-23 08:00AM
Jan-06-23 09:40AM
Jan-04-23 08:00AM
Dec-29-22 06:02AM
Nov-14-22 04:01PM
Nov-09-22 04:01PM
Nov-07-22 04:01PM
Nov-01-22 08:00AM
Oct-24-22 08:00AM
Sep-08-22 12:44PM
Aug-15-22 11:00PM
Aug-08-22 04:15PM
Aug-01-22 10:30AM
Jul-26-22 04:15PM
Jun-08-22 08:00AM
May-16-22 10:00PM
May-11-22 05:08PM
Apr-27-22 08:00AM
Apr-02-22 12:00AM
Apr-01-22 05:01PM
Mar-28-22 04:05PM
Mar-16-22 04:15PM
Dec-30-21 04:16AM
Nov-25-21 07:35AM
Nov-15-21 08:00AM
Nov-08-21 08:00AM
Nov-02-21 08:00AM
Oct-07-21 08:00AM
Oct-01-21 06:05AM
Aug-16-21 04:05PM
Jul-23-21 07:13PM
Jul-01-21 05:02PM
Jun-30-21 10:44PM
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OConnell Daniel JosephPresident and CEOJan 19Sale3.4715,20052,753502,485Jan 19 07:07 PM
Meisner Derek MChief Legal Officer & Corp SecJan 19Sale3.488,93331,048108,867Jan 19 07:06 PM
Zuga MattCFO & Chief Business OfficerJan 18Sale3.714,24215,717211,445Jan 19 07:05 PM
Siemers EricChief Medical OfficerJan 18Sale3.713,12411,604117,576Jan 19 07:05 PM
Barton RussellChief Operating OfficerJan 18Sale3.732,83310,55596,867Jan 19 07:04 PM
Ives Jeffrey L.DirectorAug 17Option Exercise0.7541,94931,51939,149Aug 18 06:31 PM
Ives Jeffrey L.DirectorAug 17Sale6.4941,949272,3340Aug 18 06:31 PM
RA CAPITAL MANAGEMENT, L.P.DirectorJul 21Buy7.755,161,29039,999,99813,043,179Jul 25 04:30 PM